Page 45 - Michael Erman News Today

By Michael Erman (Reuters) -Pfizer's plan to as much as quadruple current U.S. prices for its COVID-19 vaccines going forward could spur revenue for years, analysts said. The drugmaker, which developed and sells the vaccine

By Michael Erman

By Michael Erman NEW YORK (Reuters) - With most Americans delaying or skipping new COVID-19 booster shots, analysts and investors are now predicting f...

NEW YORK (Reuters) - Pfizer Inc expects to charge about $110 to $130 per dose for its COVID-19 vaccine after the United States government's current pr...

By Michael Erman NEW YORK (Reuters) -Pfizer Inc expects to raise the price of its COVID-19 vaccine to about $110 to $130 per dose after the United Sta...

(Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) advisory committee on vaccines on Thursday approved adding COVID-19 vaccines to ...

(Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) advisory committee on vaccines on Thursd...

The U.S. Centers for Disease Control and Prevention advisory committee on vaccines on Thursday approved adding COVID-19 vaccines to the agencys recommended immunization schedules for both...

By Ahmed Aboulenein and Michael Erman WASHINGTON (Reuters) -The White House expects the rate of vaccination in its fall booster campaign to pick up ov...

By Michael Erman NEW YORK (Reuters) - Around two-thirds of adults in the United States do not plan to get updated COVID-19 booster shots soon, accordi...